Literature DB >> 22545245

Using modeling to help understand vaginal microbicide functionality and create better products.

David F Katz1, Yajing Gao, Meng Kang.   

Abstract

A summary is presented of a range of mathematical models that relate to topical microbicidal molecules, applied vaginally to inhibit HIV transmission. These models contribute to the fundamental understanding of the functioning of those molecules, as introduced in different delivery systems. They also provide computational tools that can be employed in the practical design and evaluation of vaginal microbicide products. Mathematical modeling can be implemented, using stochastic principles, to understand the probability of infection by sexually transmitted HIV virions. This provides a frame of reference for the deterministic models of the various processes that underlie HIV transmission and its inhibition, including: the temporal and spatial history of HIV migration from semen to vaginal epithelial surfaces and thence to the underlying stroma; the time and spatial distribution of microbicidal drugs as delivered by various vehicles (e.g., gels, rings, films, and tablets)-this is central to understanding microbicide product pharmacokinetics; and the time and space history of the drug interactions with HIV directly and with host cells for HIV within the vaginal environment-this informs the understanding of microbicide pharmacodynamics. Models that characterize microbicide functionality and performance should and can interface with both in vitro and in vivo experimental studies. They can serve as a rapidly applied, inexpensive tool, to facilitate microbicide R&D, in advance of more costly and time consuming clinical trials.

Entities:  

Year:  2011        PMID: 22545245      PMCID: PMC3337038          DOI: 10.1007/s13346-011-0029-z

Source DB:  PubMed          Journal:  Drug Deliv Transl Res        ISSN: 2190-393X            Impact factor:   4.617


  41 in total

Review 1.  Modelling viral and immune system dynamics.

Authors:  Alan S Perelson
Journal:  Nat Rev Immunol       Date:  2002-01       Impact factor: 53.106

2.  Design of a semisolid vaginal microbicide gel by relating composition to properties and performance.

Authors:  Alamelu Mahalingam; Eric Smith; Judit Fabian; Festo R Damian; Jennifer J Peters; Meredith R Clark; David R Friend; David F Katz; Patrick F Kiser
Journal:  Pharm Res       Date:  2010-09-15       Impact factor: 4.200

3.  The optimal analysis of MRI data to quantify the distribution of a microbicide.

Authors:  Kurt T Barnhart; E Scott Pretorius; David M Shera; Mayadah Shabbout; Alka Shaunik
Journal:  Contraception       Date:  2005-09-19       Impact factor: 3.375

4.  A model of transluminal flow of an anti-HIV microbicide vehicle: Combined elastic squeezing and gravitational sliding.

Authors:  Andrew J Szeri; Su Chan Park; Stéphane Verguet; Aaron Weiss; David F Katz
Journal:  Phys Fluids (1994)       Date:  2008-08-21       Impact factor: 3.521

5.  Transport theory for HIV diffusion through in vivo distributions of topical microbicide gels.

Authors:  Bonnie E Lai; Marcus H Henderson; Jennifer J Peters; David K Walmer; David F Katz
Journal:  Biophys J       Date:  2009-11-04       Impact factor: 4.033

Review 6.  Development of topical microbicides to prevent the sexual transmission of HIV.

Authors:  Robert W Buckheit; Karen M Watson; Kathleen M Morrow; Anthony S Ham
Journal:  Antiviral Res       Date:  2009-10-27       Impact factor: 5.970

7.  Stochastic modeling of the dynamics of CD4+ T-cell infection by HIV and some Monte Carlo studies.

Authors:  W Y Tan; H Wu
Journal:  Math Biosci       Date:  1998-01-15       Impact factor: 2.144

8.  Advances in the Development of Microbicides for the Prevention of HIV Infection.

Authors:  Lucio R Minces; Ian McGowan
Journal:  Curr Infect Dis Rep       Date:  2010-01       Impact factor: 3.725

9.  Interpreting properties of microbicide drug delivery gels: analyzing deployment kinetics due to squeezing.

Authors:  Sarah L Kieweg; David F Katz
Journal:  J Pharm Sci       Date:  2007-04       Impact factor: 3.534

10.  Vaginal microbicide gel for delivery of IQP-0528, a pyrimidinedione analog with a dual mechanism of action against HIV-1.

Authors:  Alamelu Mahalingam; Adam P Simmons; Shweta R Ugaonkar; Karen M Watson; Charlene S Dezzutti; Lisa C Rohan; Robert W Buckheit; Patrick F Kiser
Journal:  Antimicrob Agents Chemother       Date:  2011-01-18       Impact factor: 5.191

View more
  14 in total

1.  Designing preclinical perceptibility measures to evaluate topical vaginal gel formulations: relating user sensory perceptions and experiences to formulation properties.

Authors:  Kathleen M Morrow; Joseph L Fava; Rochelle K Rosen; Sara Vargas; Julia G Shaw; E Milu Kojic; Patrick F Kiser; David R Friend; David F Katz
Journal:  AIDS Res Hum Retroviruses       Date:  2013-12-09       Impact factor: 2.205

Review 2.  Vaginal drug distribution modeling.

Authors:  David F Katz; Andrew Yuan; Yajing Gao
Journal:  Adv Drug Deliv Rev       Date:  2015-04-28       Impact factor: 15.470

3.  Full depth measurement of tenofovir transport in rectal mucosa using confocal Raman spectroscopy and optical coherence tomography.

Authors:  Aubrey L Presnell; Oranat Chuchuen; Morgan G Simons; Jason R Maher; David F Katz
Journal:  Drug Deliv Transl Res       Date:  2018-06       Impact factor: 4.617

4.  Transient spreading and swelling behavior of a gel deploying an anti-HIV topical microbicide.

Authors:  Savas Tasoglu; David F Katz; Andrew J Szeri
Journal:  J Nonnewton Fluid Mech       Date:  2012-11       Impact factor: 2.670

5.  Monitoring vaginal epithelial thickness changes noninvasively in sheep using optical coherence tomography.

Authors:  Kathleen L Vincent; Gracie Vargas; Jingna Wei; Nigel Bourne; Massoud Motamedi
Journal:  Am J Obstet Gynecol       Date:  2013-01-17       Impact factor: 8.661

6.  Effects of gel volume on pharmacokinetics for vaginal and rectal applications of combination DuoGel-IQB4012, a dual chamber-dual drug HIV microbicide gel, in pigtailed macaques.

Authors:  Lara E Pereira; Tyana Singletary; Amy Martin; Chuong T Dinh; Frank Deyounks; Angela Holder; Janet McNicholl; Karen W Buckheit; Robert W Buckheit; Anthony Ham; David F Katz; James M Smith
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

7.  In vivo optical imaging of human vaginal gel thickness distributions with a probe-based, dual-modality instrument.

Authors:  Tyler K Drake; Michael G DeSoto; Jennifer J Peters; Marcus H Henderson; Bonnie Thiele; Tammy Sinclair Bishop; Amy P Murtha; David F Katz; Adam Wax
Journal:  J Biomed Opt       Date:  2012-11       Impact factor: 3.170

8.  Pharmacokinetics and pharmacodynamics of the reverse transcriptase inhibitor tenofovir and prophylactic efficacy against HIV-1 infection.

Authors:  Sulav Duwal; Christof Schütte; Max von Kleist
Journal:  PLoS One       Date:  2012-07-11       Impact factor: 3.240

9.  Vaginal deployment and tenofovir delivery by microbicide gels.

Authors:  Y Gao; A Yuan; O Chuchuen; A Ham; K H Yang; D F Katz
Journal:  Drug Deliv Transl Res       Date:  2015-06       Impact factor: 4.617

10.  Multicompartmental pharmacokinetic model of tenofovir delivery by a vaginal gel.

Authors:  Yajing Gao; David F Katz
Journal:  PLoS One       Date:  2013-09-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.